Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Karzinoidtumore der Lunge

In einigen Karzinoidtumoren der Lunge können somatische Mutationen des MEN1-Gens gefunden werden.

Gliederung

Erbliche Tumorerkrankungen
Hereditäre Hirntumoren
Hereditäre Nierentumoren
Hereditäre maligne Bluterkrankungen
Infantiles kapilläres Hämangiom
Karzinoidtumore der Lunge
MEN1
Lipom
Lymphangioleiomyomatose
Magenkarzinom
Multiple selbsheilende palmoplantare Karzinome
Neigung zu Kaposi-Sarkomen
Neurofibromatose

Referenzen:

1.

Wautot V et al. (2002) Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

external link
2.

Kjellman M et al. (1999) Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.

external link
3.

Gisselsson D et al. (1999) Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics.

external link
4.

Cebrián A et al. (1999) Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1.

external link
5.

Schulte KM et al. (1999) MEN I gene mutations in sporadic adrenal adenomas.

external link
6.

Tahara H et al. (2000) Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.

external link
7.

Stratakis CA et al. (2000) Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

external link
8.

Crabtree JS et al. (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

external link
9.

Kaji H et al. (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

external link
10.

Pannett AA et al. (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis.

external link
11.

Guo SS et al. (2001) Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

external link
12.

Sato K et al. (2001) Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.

external link
13.

Turner JJ et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1.

external link
14.

Agarwal SK et al. (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

external link
15.

Okamoto H et al. (2002) A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism.

external link
16.

Park JH et al. (2003) Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders.

external link
17.

Zablewska B et al. (2003) Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse.

external link
18.

Balogh K et al. (2004) Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene.

external link
19.

Ebeling T et al. (2004) Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.

external link
20.

Carrasco CA et al. (2004) Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism.

external link
21.

Busygina V et al. (2004) Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.

external link
22.

Yokoyama A et al. (2005) The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

external link
23.

Chen YX et al. (2006) The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.

external link
24.

Canaff L et al. (2012) Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

external link
25.

Huang J et al. (2012) The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.

external link
26.

Guru SC et al. (1998) Menin, the product of the MEN1 gene, is a nuclear protein.

external link
27.

Jiao Y et al. (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

external link
28.

Lin SY et al. (2003) Multiple tumor suppressor pathways negatively regulate telomerase.

external link
29.

Bear JC et al. (1985) Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA.

external link
30.

Farid NR et al. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors.

external link
31.

Chandrasekharappa SC et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1.

external link
32.

Agarwal SK et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

external link
33.

Lemmens I et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

external link
34.

Darling TN et al. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.

external link
35.

Heppner C et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours.

external link
36.

Debelenko LV et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.

external link
37.

Bassett JH et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1.

external link
38.

Frank-Raue K et al. (2005) Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.

external link
39.

Vortmeyer AO et al. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas.

external link
40.

Prezant TR et al. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.

external link
41.

Olufemi SE et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.

external link
42.

Giraud S et al. (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

external link
43.

Teh BT et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

external link
44.

Farnebo F et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors.

external link
45.

Carling T et al. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.

external link
46.

Böni R et al. (1998) Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas.

external link
47.

Teh BT et al. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

external link
48.

Fujimori M et al. (1998) Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism.

external link
49.

Heppner C et al. (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms.

external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz